Embecta (EMBC) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Embecta (EMBC) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.38% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -282.67% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -25.78% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 9.23% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 56.71% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -188.83% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 20.94% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -96.77% |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | -117.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.45% |
| Sep 30, 2025 | 80.82% |
| Jun 30, 2025 | 209.52% |
| Mar 31, 2025 | -18.69% |
| Sep 30, 2024 | 143.33% |
| Jun 30, 2024 | -3.29% |
| Mar 31, 2024 | 106.43% |
| Dec 31, 2023 | -42.90% |
| Sep 30, 2023 | 134.88% |
| Jun 30, 2023 | -75.64% |
| Mar 31, 2023 | -82.41% |
| Dec 31, 2022 | -64.37% |
| Sep 30, 2022 | -117.75% |
| Jun 30, 2022 | -40.40% |
| Mar 31, 2022 | -26.23% |
| Dec 31, 2021 | -6.17% |